Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
CF10 and EdU Drive Telomere Attrition in CRC
2026-10-05
A 2026 NAR Molecular Medicine study identifies strong, model-dependent synergy between the fluoropyrimidine polymer CF10 and EdU in colorectal cancer cells. The evidence links enhanced EdU incorporation with DNA double-strand breaks, cell-cycle disruption, reduced telomere staining, and mitotic catastrophe, while also defining important limits on interpreting the findings as direct telomerase inhibition.
-
BIRC2 and BIRC3 Regulation in Pulmonary Epithelium
2026-10-05
Thorne et al. distinguish how inflammatory cytokines and glucocorticoids regulate BIRC2 and BIRC3 in pulmonary epithelial models. The study shows that BIRC3 is strongly inducible and pathway-sensitive, whereas BIRC2 is comparatively constitutive, refining interpretations of epithelial inflammatory signaling and cell-death protection.
-
Exosomal SNORD52 Activates JAK2/STAT6 in HCC
2026-10-04
The reference study identifies hepatoma cell-derived exosomal SNORD52 as a potential intercellular signal that promotes M2-like macrophage polarization through JAK2/STAT6 pathway activation. Its main contribution is linking a specific snoRNA cargo to tumor–macrophage communication, while the evidence remains primarily cell-based and requires broader validation before clinical or therapeutic conclusions can be drawn.
-
Vitamin C, NAC, and Cochlear Cell Senescence
2026-10-03
A 2024 Molecular Biology Reports study used a D-galactose-induced HEI-OC1 cell model to examine whether vitamin C could mitigate cochlear hair-cell senescence. Its findings associate protection with lower reactive oxygen species, reduced inflammatory signaling, and weaker NF-κB activation, while N-acetylcysteine served as a redox-oriented comparator rather than proof of a clinical treatment effect.
-
ECL Chemiluminescent Substrate Detection Kit
2026-10-01
Discover how the ECL Chemiluminescent Substrate Detection Kit can validate spatially defined glioblastoma mechanisms, from TrkB-associated tumour–neuron interactions to membrane-based protein and nucleic acid analysis. This guide connects cancer-neuroscience discoveries with rigorous Western blot chemiluminescence detection and translational assay design.
-
JC-1 Assays for Mitochondrial Apoptosis
2026-10-01
Use JC-1 as a ratiometric mitochondrial membrane potential assay to connect treatment response with mitochondrial dysfunction and apoptosis. This workflow translates the STAT3–DRP1 findings in anaplastic thyroid carcinoma into practical live-cell, imaging, and flow-cytometry readouts.
-
EZ Cap™ Cre mRNA (m1Ψ) Workflow Guide
2026-10-01
Build cleaner, transient Cre-loxP assays with a Cap 1, poly(A)-tailed, m1Ψ-modified mRNA payload. This guide connects practical cell-based recombination workflows with lung-targeted RNA delivery research, while separating validated product features from application-specific optimization.
-
PreScission Protease (PSP): Tag Cleavage Guide
2026-09-30
PreScission Protease (PSP), SKU K1101, is an HRV 3C protease fusion enzyme for removing engineered affinity tags from recombinant proteins at a defined Gln-Gly junction. It should be used only when the specified recognition sequence is present and accessible, with cleavage performed under validated low-temperature conditions rather than as a universal protease treatment.
-
Diethylmaleate: GST Inhibition Workflow
2026-09-29
Diethylmaleate provides a practical way to deplete intracellular glutathione and test whether GST-dependent antioxidant defense drives stress resistance. This workflow connects biochemical readouts, insecticide-sensitivity assays, and carefully controlled cellular toxicology experiments.
-
IEM 1460: AMPA Receptor Blocker Workflows
2026-09-29
IEM 1460 enables targeted AMPA receptor inhibition assays that connect fast synaptic signaling with excitotoxicity and neuronal survival. This workflow guide distinguishes selective AMPA blockade from the dual-receptor strategy reported for IEM-1925, helping researchers choose appropriate readouts, controls, and troubleshooting steps.
-
FPH1 (BRD-6125) Hepatocyte Expansion
2026-09-28
FPH1, also called BRD-6125, is a small molecule reported to promote functional proliferation of primary human hepatocytes and to improve selected maturation readouts in iPSC-derived hepatocyte-like cells. Its practical value is best assessed with paired proliferation and function measurements, including nuclei count, mitotic activity, albumin secretion, CYP3A4, and AFP.
-
ECL Chemiluminescent Substrate Detection Kit in Ferroptosis
2026-09-28
See how the ECL Chemiluminescent Substrate Detection Kit can support interpretation of ferroptosis-related Western blots in carbon-ion radiotherapy research. This article connects HRP-based detection chemistry with evidence from a gastric cancer study while distinguishing protein readouts from functional proof of ferroptosis.
-
PTEN mRNA: From Pathway Biology to Delivery Strategy
2026-09-27
PTEN mRNA experiments are most informative when transcript design, delivery, pathway response and disease context are evaluated together. Explore how EZ Cap™ Human PTEN mRNA can support rigorous cancer research and delivery-platform development, including a cautious look at emerging brain-targeted LNP findings.
-
ECL Chemiluminescent Substrate Detection Kit in CIRT
2026-09-26
See how the ECL Chemiluminescent Substrate Detection Kit can help evaluate protein-level evidence in carbon-ion radiotherapy and ferroptosis research. This article focuses on interpreting DHODH, ACSL4, and GPX4 results within a broader evidence chain—not simply running a Western blot.
-
ISRIB Blocks Natural and Epilepsy-Linked Forgetting
2026-09-26
A mouse study links activation of the integrated stress response (ISR) with both natural forgetting of established recognition memories and seizure-associated accelerated forgetting. Repeated ISRIB treatment during memory retention limited forgetting in both settings, while a single treatment did not prevent natural forgetting or alter retrieval, highlighting the importance of timing and treatment schedule.